tiprankstipranks
Trending News
More News >
Bayer (BAYZF)
OTHER OTC:BAYZF
US Market

Bayer (BAYZF) Stock Forecast & Price Target

Compare
110 Followers
See the Price Targets and Ratings of:

BAYZF Analyst Ratings

Hold
13Ratings
2 Buy
11 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Bayer
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BAYZF Stock 12 Month Forecast

Average Price Target

$29.80
▲(8.36% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Bayer in the last 3 months. The average price target is $29.80 with a high forecast of $37.28 and a low forecast of $22.59. The average price target represents a 8.36% change from the last price of $27.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"$18","23":"$23","28":"$28","33":"$33","38":"$38"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":37.27614,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$37.28</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.7983204,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$29.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.5916,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$22.59</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,23,28,33,38],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.58,26.479703076923077,27.37940615384615,28.27910923076923,29.178812307692304,30.078515384615383,30.97821846153846,31.877921538461536,32.77762461538461,33.67732769230769,34.57703076923077,35.47673384615385,36.37643692307692,{"y":37.27614,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.58,25.904486184615383,26.228972369230767,26.553458553846152,26.877944738461537,27.20243092307692,27.526917107692306,27.851403292307694,28.17588947692308,28.500375661538463,28.824861846153848,29.149348030769232,29.473834215384617,{"y":29.7983204,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.58,25.350123076923076,25.120246153846153,24.89036923076923,24.660492307692305,24.430615384615383,24.20073846153846,23.970861538461538,23.740984615384615,23.511107692307693,23.281230769230767,23.051353846153845,22.821476923076922,{"y":22.5916,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.16,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.429,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.882,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.489,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.745,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.431,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.1,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.049,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.681,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.213,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":23.348,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.925,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.58,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$37.28Average Price Target$29.80Lowest Price Target$22.59
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
$31.63
Hold
15.01%
Upside
Reiterated
03/05/25
Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating
Deutsche Bank
$25.98
Hold
-5.53%
Downside
Reiterated
03/05/25
Bayer (0P6S) Gets a Hold from Deutsche Bank
Morgan Stanley
$33.89$29.37
Hold
6.80%
Upside
Reiterated
02/12/25
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR26 at Morgan StanleyMorgan Stanley analyst James Quigley lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR26.00 (from EUR30.00) while maintaining a Equalweight rating.
CFRA
$32.76$28.24
Hold
2.69%
Upside
Reiterated
11/19/24
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR25 at CFRACFRA analyst Wan Nurhayati lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR25.00 (from EUR29.00) while maintaining a Hold rating.
BMO Capital
$33.89$29.37
Hold
6.80%
Upside
Reiterated
11/13/24
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR26 at BMO CapitalBMO Capital analyst Joel Jackson lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR26.00 (from EUR30.00) while maintaining a Market Perform rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
$31.63
Hold
15.01%
Upside
Reiterated
03/05/25
Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating
Deutsche Bank
$25.98
Hold
-5.53%
Downside
Reiterated
03/05/25
Bayer (0P6S) Gets a Hold from Deutsche Bank
Morgan Stanley
$33.89$29.37
Hold
6.80%
Upside
Reiterated
02/12/25
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR26 at Morgan StanleyMorgan Stanley analyst James Quigley lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR26.00 (from EUR30.00) while maintaining a Equalweight rating.
CFRA
$32.76$28.24
Hold
2.69%
Upside
Reiterated
11/19/24
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR25 at CFRACFRA analyst Wan Nurhayati lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR25.00 (from EUR29.00) while maintaining a Hold rating.
BMO Capital
$33.89$29.37
Hold
6.80%
Upside
Reiterated
11/13/24
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR26 at BMO CapitalBMO Capital analyst Joel Jackson lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR26.00 (from EUR30.00) while maintaining a Market Perform rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bayer

Which Analyst Should I Follow If I Want to Buy BAYZF and Sell After:
1 Month
xxx
Success Rate
10/29 ratings generated profit
34%
Average Return
-2.24%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 34.48% of your transactions generating a profit, with an average return of -2.24% per trade.
3 Months
xxx
Success Rate
15/29 ratings generated profit
52%
Average Return
-2.57%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 51.72% of your transactions generating a profit, with an average return of -2.57% per trade.
1 Year
Peter SpenglerDZ BANK AG
Success Rate
9/29 ratings generated profit
31%
Average Return
-12.85%
reiterated a buy rating last month
Copying Peter Spengler's trades and holding each position for 1 Year would result in 31.03% of your transactions generating a profit, with an average return of -12.85% per trade.
2 Years
xxx
Success Rate
7/29 ratings generated profit
24%
Average Return
-18.17%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 24.14% of your transactions generating a profit, with an average return of -18.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BAYZF Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
2
0
1
1
2
Hold
24
10
21
24
21
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
10
22
25
23
In the current month, BAYZF has received 2 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. BAYZF average Analyst price target in the past 3 months is 29.80.
Each month's total comprises the sum of three months' worth of ratings.

BAYZF Financial Forecast

BAYZF Earnings Forecast

Next quarter’s earnings estimate for BAYZF is $2.47 with a range of $1.90 to $2.75. The previous quarter’s EPS was $1.19. BAYZF beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.49% of the time in the same period. In the last calendar year BAYZF has Outperformed its overall industry.
Next quarter’s earnings estimate for BAYZF is $2.47 with a range of $1.90 to $2.75. The previous quarter’s EPS was $1.19. BAYZF beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.49% of the time in the same period. In the last calendar year BAYZF has Outperformed its overall industry.

BAYZF Sales Forecast

Next quarter’s sales forecast for BAYZF is $15.14B with a range of $14.79B to $15.46B. The previous quarter’s sales results were $13.25B. BAYZF beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.38% of the time in the same period. In the last calendar year BAYZF has Outperformed its overall industry.
Next quarter’s sales forecast for BAYZF is $15.14B with a range of $14.79B to $15.46B. The previous quarter’s sales results were $13.25B. BAYZF beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.38% of the time in the same period. In the last calendar year BAYZF has Outperformed its overall industry.

BAYZF Stock Forecast FAQ

What is BAYZF’s average 12-month price target, according to analysts?
Based on analyst ratings, Bayer’s 12-month average price target is 29.80.
    What is BAYZF’s upside potential, based on the analysts’ average price target?
    Bayer has 8.36% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BAYZF a Buy, Sell or Hold?
          Bayer has a consensus rating of Hold which is based on 2 buy ratings, 11 hold ratings and 0 sell ratings.
            What is Bayer’s price target?
            The average price target for Bayer is 29.80. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $37.28 ,the lowest forecast is $22.59. The average price target represents 8.36% Increase from the current price of $27.5.
              What do analysts say about Bayer?
              Bayer’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of BAYZF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis